VINC
Bank of America’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15
| Closed | -$8 | – | 7566 |
|
|
2025
Q1 | $8 | Sell |
15
-222
| -94% | -$118 | ﹤0.01% | 7168 |
|
|
2024
Q4 | $62 | Buy |
237
+26
| +12% | +$7 | ﹤0.01% | 6905 |
|
|
2024
Q3 | $151 | Buy |
211
+1
| +0.5% | +$1 | ﹤0.01% | 6699 |
|
|
2024
Q2 | $170 | Sell |
210
-701,213
| -100% | -$568K | ﹤0.01% | 6695 |
|
|
2024
Q1 | $3.55M | Sell |
701,423
-381,440
| -35% | -$1.93M | ﹤0.01% | 3331 |
|
|
2023
Q4 | $1.28M | Sell |
1,082,863
-370,044
| -25% | -$437K | ﹤0.01% | 3969 |
|
|
2023
Q3 | $1.47M | Buy |
1,452,907
+1,449,152
| +38,593% | +$1.46M | ﹤0.01% | 3767 |
|
|
2023
Q2 | $4.88K | Buy |
3,755
+848
| +29% | +$1.1K | ﹤0.01% | 6115 |
|
|
2023
Q1 | $3.02K | Sell |
2,907
-30
| -1% | -$31 | ﹤0.01% | 6335 |
|
|
2022
Q4 | $3K | Sell |
2,937
-4,259
| -59% | -$4.34K | ﹤0.01% | 6335 |
|
|
2022
Q3 | $10K | Sell |
7,196
-809
| -10% | -$1.12K | ﹤0.01% | 6373 |
|
|
2022
Q2 | $11K | Sell |
8,005
-4,761
| -37% | -$6.54K | ﹤0.01% | 6541 |
|
|
2022
Q1 | $51K | Sell |
12,766
-5,204
| -29% | -$20.8K | ﹤0.01% | 6378 |
|
|
2021
Q4 | $183K | Buy |
17,970
+7,737
| +76% | +$78.8K | ﹤0.01% | 5742 |
|
|
2021
Q3 | $165K | Buy |
10,233
+1,483
| +17% | +$23.9K | ﹤0.01% | 5587 |
|
|
2021
Q2 | $114K | Buy |
8,750
+8,579
| +5,017% | +$112K | ﹤0.01% | 5664 |
|
|
2021
Q1 | $3K | Buy |
+171
| New | +$3K | ﹤0.01% | 6491 |
|
|
2020
Q4 | – | Sell |
-599
| Closed | -$7K | – | 6524 |
|
|
2020
Q3 | $7K | Buy |
+599
| New | +$7K | ﹤0.01% | 5865 |
|